Drägerwerk AG & Co. KGaA Asset Resilience Ratio
Drägerwerk AG & Co. KGaA asset resilience ratio. Drägerwerk AG & Co. KGaA (DRW8) has an Asset Resilience Ratio of 7.45% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Drägerwerk AG & Co. KGaA carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Drägerwerk AG & Co. KGaA (2006–2024)
Asset resilience ratio of Drägerwerk AG & Co. KGaA from 2006 to 2024. This chart shows how Drägerwerk AG & Co. KGaA's Asset Resilience Ratio has changed over time. See cash generation quality of Drägerwerk AG & Co. KGaA to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Drägerwerk AG & Co. KGaA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Drägerwerk AG & Co. KGaA balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €188.28 Million | 6.21% |
| Short-term Investments | €37.53 Million | 1.24% |
| Total Liquid Assets | €225.81 Million | 7.45% |
Asset Resilience Insights
- Limited Liquidity: Drägerwerk AG & Co. KGaA maintains only 7.45% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Drägerwerk AG & Co. KGaA Industry Peers by Asset Resilience Ratio
Compare Drägerwerk AG & Co. KGaA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
Drägerwerk AG & Co. KGaA Asset Resilience Ratio by Year (2006–2024)
Drägerwerk AG & Co. KGaA asset resilience ratio by year from 2006 to 2024. The table below shows the annual Asset Resilience Ratio data for Drägerwerk AG & Co. KGaA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 8.02% | €248.18 Million ≈ $290.15 Million |
€3.09 Billion ≈ $3.62 Billion |
-0.62pp |
| 2023-12-31 | 8.64% | €267.40 Million ≈ $312.62 Million |
€3.09 Billion ≈ $3.62 Billion |
-1.23pp |
| 2022-12-31 | 9.87% | €306.67 Million ≈ $358.53 Million |
€3.11 Billion ≈ $3.63 Billion |
-8.29pp |
| 2021-12-31 | 18.17% | €577.38 Million ≈ $675.01 Million |
€3.18 Billion ≈ $3.72 Billion |
-1.16pp |
| 2020-12-31 | 19.33% | €639.08 Million ≈ $747.15 Million |
€3.31 Billion ≈ $3.87 Billion |
+11.88pp |
| 2019-12-31 | 7.45% | €191.50 Million ≈ $223.89 Million |
€2.57 Billion ≈ $3.01 Billion |
+0.12pp |
| 2018-12-31 | 7.33% | €176.65 Million ≈ $206.53 Million |
€2.41 Billion ≈ $2.82 Billion |
-3.00pp |
| 2017-12-31 | 10.33% | €243.19 Million ≈ $284.31 Million |
€2.35 Billion ≈ $2.75 Billion |
+0.96pp |
| 2016-12-31 | 9.37% | €216.67 Million ≈ $253.31 Million |
€2.31 Billion ≈ $2.70 Billion |
+9.23pp |
| 2015-12-31 | 0.14% | €3.15 Million ≈ $3.68 Million |
€2.31 Billion ≈ $2.70 Billion |
+0.00pp |
| 2014-12-31 | 0.14% | €3.03 Million ≈ $3.55 Million |
€2.23 Billion ≈ $2.61 Billion |
-1.47pp |
| 2013-12-31 | 1.60% | €33.12 Million ≈ $38.73 Million |
€2.07 Billion ≈ $2.41 Billion |
+1.95pp |
| 2012-12-31 | -0.34% | €-7.18 Million ≈ $-8.40 Million |
€2.10 Billion ≈ $2.46 Billion |
-1.28pp |
| 2011-12-31 | 0.94% | €19.88 Million ≈ $23.25 Million |
€2.12 Billion ≈ $2.47 Billion |
-0.20pp |
| 2010-12-31 | 1.14% | €22.51 Million ≈ $26.32 Million |
€1.98 Billion ≈ $2.31 Billion |
-0.38pp |
| 2009-12-31 | 1.52% | €28.70 Million ≈ $33.55 Million |
€1.89 Billion ≈ $2.20 Billion |
-0.04pp |
| 2008-12-31 | 1.56% | €25.86 Million ≈ $30.24 Million |
€1.65 Billion ≈ $1.93 Billion |
+0.58pp |
| 2007-12-31 | 0.98% | €16.06 Million ≈ $18.78 Million |
€1.64 Billion ≈ $1.91 Billion |
-1.90pp |
| 2006-12-31 | 2.88% | €47.13 Million ≈ $55.10 Million |
€1.64 Billion ≈ $1.91 Billion |
-- |
About Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more